Revvity | PKI - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Agilent USD 990M 44M 2026-03
Align Technology USD 757.43M 20.84M 2026-06
Bio Techne USD 208.29M 17.01M 2026-03
Bio-Rad Laboratories USD 345.8M 36.4M 2026-06
Bruker USD 416M 36.2M 2026-06
Celltrion KRW 39.29B 7.7B 2026-03
Charles River Laboratories USD 348.78M 69.47M 2026-06
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Danaher USD 3.61B 20M 2026-06
Dentsply International USD 493M 66M 2026-06
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 19.61B 2.49B 2026-06
Edwards Lifesciences USD 1.35B 62.6M 2026-06
Illumina USD 770M 49M 2026-06
Intuitive Surgical USD 2.02B 193.4M 2026-06
IQVIA Holdings USD 1.44B 368M 2026-06
Kangmei Pharma CNY 238.34M 31.95M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Laboratory Of America USD 1.11B 98.2M 2026-06
Medical Developments International AUD 7.35M 7.37M 2025-06
Mesa Laboratories USD 39.75M 4.3M 2024-12
Mettler Toledo International USD 555.82M 119.62M 2026-03
Myriad Genetics USD 146.8M 3M 2025-12
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
OraSure Technologies USD 11.34M 435K 2025-12
Organigram Holdings CAD 16.41M 6.91M 2026-03
Pacific Biosciences Of California USD 15.74M 601K 2025-12
Pharma Mar EUR 44.87M 5.63M 2026-06
Qiagen NV USD 340.39M 30.78M 2026-06
Quest Diagnostics USD 906M 33M 2026-03
Quidel USD 223.9M 315.7M 2026-06
Repligen USD 110.04M 1.75M 2026-06
Revvity USD 416.87M 29.21M 2026-06
Sartorius EUR 433.1M 18.6M 2026-06
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Tilray USD 57.47M 10.16M 2025-06
Waters USD 490M 52M 2026-06
Zealand Pharma A/S 34M 34.92M 2026-03
Zz Pientze Pharmaceu CNY 1.16B 860.2M 2026-03